We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Authors
Askanase, Anca D.; Zhao, Enxu; Zhu, Julie; Bilyk, Roman; Furie, Richard A.
- Abstract
Since APRIL and BAFF are members of the same family of proteins, can bind to the same receptors, and are both involved in B cell survival and proliferation, this oversight did not change the conclusions drawn in the manuscript of repository corticotropin injection being associated with B cell immunomodulation. Correction to: Rheumatol Ther (2020) 7:893-908 https://doi.org/10.1007/s40744-020-00236-1 In the original article published, the data we received from our CRO laboratory inadvertently labelled cytokine Tumor Necrosis Factor Ligand 13B (also known as BAFF) as Tumor Necrosis Factor Ligand 13 (also known as APRIL).
- Subjects
SYSTEMIC lupus erythematosus; INJECTIONS; ADRENOCORTICOTROPIC hormone; TUMOR necrosis factors; B cells
- Publication
Rheumatology & Therapy, 2021, Vol 8, Issue 4, p1915
- ISSN
2198-6576
- Publication type
Correction Notice
- DOI
10.1007/s40744-021-00353-5